Avanos Medical, Inc. (NYSE:AVNS – Get Free Report)’s share price traded up 6.5% during trading on Monday . The stock traded as high as $16.70 and last traded at $16.84. 460,700 shares were traded during trading, a decline of 35% from the average session volume of 705,137 shares. The stock had previously closed at $15.81.
Wall Street Analyst Weigh In
Separately, StockNews.com cut shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.
Avanos Medical Price Performance
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in AVNS. Tributary Capital Management LLC grew its holdings in Avanos Medical by 38.1% in the 4th quarter. Tributary Capital Management LLC now owns 893,008 shares of the company’s stock valued at $14,217,000 after buying an additional 246,379 shares in the last quarter. Barclays PLC boosted its position in shares of Avanos Medical by 446.2% in the 3rd quarter. Barclays PLC now owns 96,194 shares of the company’s stock valued at $2,311,000 after purchasing an additional 78,583 shares during the period. FMR LLC raised its position in Avanos Medical by 34.6% in the 3rd quarter. FMR LLC now owns 133,844 shares of the company’s stock valued at $3,216,000 after purchasing an additional 34,421 shares during the last quarter. AQR Capital Management LLC grew its stake in shares of Avanos Medical by 21.0% in the 2nd quarter. AQR Capital Management LLC now owns 146,983 shares of the company’s stock valued at $2,875,000 after purchasing an additional 25,467 shares during the last quarter. Finally, Janney Montgomery Scott LLC lifted its stake in shares of Avanos Medical by 194.3% in the 3rd quarter. Janney Montgomery Scott LLC now owns 35,918 shares of the company’s stock worth $863,000 after acquiring an additional 23,714 shares during the period. Hedge funds and other institutional investors own 95.17% of the company’s stock.
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Recommended Stories
- Five stocks we like better than Avanos Medical
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Sizing Up a New Opportunity for NVIDIA Investors
- Canada Bond Market Holiday: How to Invest and Trade
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Breakout Stocks: What They Are and How to Identify Them
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.